Irnotop 100mg Injection
Marketer
Metta Life Sciences Private Limited
Salt Composition
Irinotecan (100mg)
Overview Irnotop 100mg Injection
Oncotop 100mg Injection treats colorectal cancer by inhibiting or retarding cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician, varying based on your condition. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may not be apparent for weeks or months; discontinue only under medical guidance. Common side effects include weariness, nausea, emesis, debility, and alopecia. This medication can suppress blood cell counts (red and white blood cells), potentially increasing infection risk. Report fever, pharyngitis, or persistent diarrhea to your doctor. Regular blood tests monitor blood cell levels, along with cardiac, hepatic, and uric acid parameters. Prior to commencing treatment, disclose any pre-existing heart, liver, or kidney conditions, and all other medications, particularly anti-infectives, as drug interactions are possible. This medication is contraindicated during pregnancy and lactation; reliable contraception is essential for both partners throughout treatment.
Primary Ingredients of Irnotop 100mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Irnotop 100mg Injection
Colorectal cancer
Major Benefits of Irnotop 100mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
Common Side effects of Irnotop 100mg Injection:
- Fatigue
- Nausea
- Vomiting
- Weakness
- Hair loss
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Decreased appetite
- Mucosal inflammation
How to use Irnotop 100mg Injection:
The medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Irnotop 100mg Injection works:
In cancer treatment, the injectable drug Irnotop 100mg targets topoisomerase I, a crucial enzyme in DNA replication within cancerous cells. By inhibiting this enzyme's function, Irnotop hinders cancer cell proliferation, ultimately leading to their demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Irnotop 100mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Irnotop 100mg Injection to pregnant individuals poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may be made in life-threatening circumstances where a physician deems the potential benefits outweigh the inherent dangers. Always seek medical advice.
Breast feedingUNSAFE
Administration of Irnotop 100mg Injection is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates a risk of harmful effects to the nursing infant.
DrivingUNSAFE
Administering Irnotop 100mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects manifest.
KidneySAFE IF PRESCRIBED
The use of Irnotop 100mg Injection in individuals with impaired kidney function appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary; however, medical advice is essential. This medication is contraindicated for patients undergoing dialysis.
LiverCONSULT YOUR DOCTOR
Data on Irnotop 100mg Injection use in individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Irnotop 100mg Injection :
Should you forget a dose of Irnotop 100mg Injection, seek your physician's advice.
Facts to Know About Irnotop 100mg Injection
| Label | Value |
|---|---|
| Chemical Category | Camptothecin Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavior Class | Topoisomerase inhibitor |
3,018 People bought this recently